Sign in to view content

Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months

Brittney Statler, MD

Video
Published 2020

Related

Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID
Rishi P. Singh, MD
Annual Meeting Talks
2019
Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved Diabetic Macular Edema
Carl W. Baker, MD, FASRS
Updates from the Field
2019
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019

Category: Diabetic Retinopathy

See more